Cocktail Auour

In this week's episode, we are honored to have as our guest Martin Palmer, a world-renown theologian, the religious adviser to the late Prince Philip, and the founder of FaithInvest. We also welcome back Mike Even, known as the invest side of FaithInvest.
Within the episode, we look back at how the various global religions invested their funds and the work Martin is doing to align their investments to their faith. We hope you enjoy!

Prior to co-founding Biomatics Capital Partners in 2016, Ms. Sunderland was director of Program Related Investments for the Bill & Melinda Gates Foundation. She led the foundation’s $1.5 billion strategic investment pool, which focused on global health, global development and education. She funded 50 investments, including 30 in health care, and built a team of 10 investment professionals.

Ms. Sunderland also chaired Bill & Melinda Gates Foundation’s investment committee, which reviews all program-related investments. Prior to that role, she advised foundations, development finance institutions and governments on venture capital, SME financing and technical assistance programs. Ms. Sunderland holds a B.A. from Harvard University, an MBA from Wharton Business School and an M.A. from Johns Hopkins School of Advanced International Studies.

Ms. Sunderland sits on the Board of Directors for several of Biomatics’ portfolio companies including Aledade, BlackThorn, eGenesis and Verana.

Have you heard of the term 'k-shaped recovery'? Well, Peter was the one that immortalized that term to describe the post pandemic shutdown economic recovery.
Peter has a long history of being involved with the financial markets but changed his focus after the 2008 financial crisis and became a professor. His research focuses on confidence. Peter is an expert in how changes in confidence consistently and predictably impact our preferences, decisions and actions.
Please note that this was recorded in the late fall of 2021.

Jamie is a serial entrepreneur whose focus changed once he found out about his brothers illness. Jamie is pushing to change how medical research is performed and how it can be delivered in a more effective way.

Greg teaches the capstone course Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on non-profit advisory boards. Greg writes about innovation for Forbes.